Author: Arvin Arvin
Navigating coronavirus | finnCap & Cavendish are open for business
Categories: NewsNavigating coronavirus | finnCap & Cavendish are open for business The impact of the COVID-19 pandemic hits us all very hard, including the UK business community. As many activities come to a standstill, sales may drop or come to a stop entirely. We must all remain proactive in planning ahead in order to navigate what’s
finnCap Research Company Notes – 17 March 2020
Categories: NewsfinnCap Research Company Notes – 17 March 2020 Best of the Best (BOTB) : Corp Investment in marketing drives further upgrades Key data BOTB’s increased investment in marketing has continued to deliver better-than-expected results, with the strong start to the second half continuing. We consequently make further forecast upgrades, despite having already raised guidance twice
Energy sector analysis: OPEC+ – The gloves come off
Categories: NewsEnergy sector analysis: OPEC+ – The gloves come off Please note: prices quoted are correct at the time of publishing Friday’s OPEC+ meeting ended in disarray with Russia baulking at Saudi’s demand for a much larger than expected 1.5mmbpd production cut to tackle the demand impact caused by the coronavirus. So not only do we
finnCap Research Company Notes – 9 March 2020
Categories: NewsfinnCap Research Company Notes – 9 March 2020 LiDCO (LID) : Corp Increased sales in China due to COVID-19 Key data LiDCO’s Chinese distribution partner, Beijing Gloryway Medical Company, has sold a small number of haemodynamic monitors in Wuhan, China, as a direct response to the COVID-19 outbreak. Haemodynamic monitoring for patients in intensive care
No waiting time for AI in healthcare
Categories: BlogNo waiting time for AI in healthcare There’s a catch-22 in the great AI debate. You’re unlikely to get a competitive, early-mover advantage unless you invest confidently in AI, but you’re reticent to invest until its success is proven. By which point your horse has bolted. Healthcare is an industry that deals daily with big
finnCap Research Company Notes – 4 March 2020
Categories: NewsfinnCap Research Company Notes – 4 March 2020 Oncimmune Holdings (ONC) : Corp Biodesix launches EarlyCDT Lung test in the US Key data Oncimmune’s exclusive commercial partner, Biodesix, has launched the EarlyCDT Lung test in the US. Biodesix will market the test as Nodify CDT, under its Nodify Lung brand. The US is one the
finnCap Research Company Notes – 3 March 2020
Categories: NewsfinnCap Research Company Notes – 3 March 2020 ANGLE (AGL) : Corp Breakthrough research in brain metastasis in NSCLC Key data Highly positive independent research, from University Medical Centre Hamburg-Eppendorf, and published in the Journal of Neuro-Oncology, suggests that Parsortix may aid in the assessment of the likelihood of a patient suffering a brain metastasis
finnCap Research Company Notes – 13 February 2020
Categories: NewsfinnCap Research Company Notes – 13 February 2020 Evgen Pharma (EVG) : Corp Investigator-led study in CKD Key data Evgen announced that it has entered into a MoU with The University of Rochester School of Medicine and Dentistry to advance SFX-01 towards a clinical trial in chronic kidney disease (CKD). Evgen will supply SFX-01 for
finnCap Tech Chat | Sharing the pain
Categories: BlogfinnCap Tech Chat | Sharing the pain finnCap Tech Chat | Sharing the pain Two hunters are out in the woods when one of them collapses. He’s not breathing so his friend calls the emergency service number. “My friend is dead! What should I do?” The operator replies, “Calm down sir, first make sure that
finnCap Research Company Notes – 27 February 2020
Categories: NewsfinnCap Research Company Notes – 27 February 2020 ANGLE (AGL) : Corp Third-party research – this time in kidney cancer Key data Mark Brewer 020 7220 0556 mbrewer@finncap.com Amino Technologies (AMO) : Corp Execution proves strategy Key data Finals for November FY19 report performance demonstrating execution of both the transformation programme announced this time last
